Pierre-Jean Pintard | Ophthalmology | Best Industrial Research Award

Dr. Pierre-Jean Pintard | Ophthalmology | Best Industrial Research Award

Medical Director at Abbvie, United Kingdom

๐Ÿ‘จโ€โš•๏ธ Dr. Pierre-Jean Pintard is a multilingual Medical Doctor based in London ๐Ÿ‡ฌ๐Ÿ‡ง, with expertise in Clinical Development, Medical Affairs, HEOR, and Pharmacovigilance. Currently Associate Global Medical Director at AbbVie, he has held key roles at Gilead, Bial, and Mylan. He holds an MD from Barts and The London, an MSc in Health Economics from LSE & LSHTM, and specialty training in Pharmaceutical Medicine. He has published in top journals and presented internationally. Fluent in French ๐Ÿ‡ซ๐Ÿ‡ท, English ๐Ÿ‡ฌ๐Ÿ‡ง, and Spanish ๐Ÿ‡ช๐Ÿ‡ธ, he is also a pianist ๐ŸŽน and certified sailing instructor โ›ต.

Publication Profile

Google Scholar

Professional Experience

Dr. Pierre-Jean Pintard is a seasoned global medical leader with extensive experience across top pharmaceutical companies. Currently serving as Associate Global Medical Director at AbbVie ๐ŸŒ, he leads clinical strategies and evidence generation for Ozurdex. At Gilead Sciences ๐Ÿ‡ช๐Ÿ‡บ, he played a pivotal role in maintaining access to Ambisome and launching Epclusa. Previously at Bial ๐Ÿ‡ต๐Ÿ‡น, he managed global medical affairs for the inflammation portfolio. At Mylan ๐Ÿ‡ฌ๐Ÿ‡ง, he launched biosimilars and provided expert medical insights. Earlier roles at Bristol Myers Squibb and William Harvey Institute honed his skills in health outcomes research and clinical science ๐Ÿ”ฌ๐Ÿ“Š

๐ŸŽ“ Educational Background

Dr. Pierre-Jean Pintard holds a diverse and interdisciplinary academic background. He completed Pharmaceutical Medicine Specialty Training (2019โ€“2020) at NOVA Medical School/University of Aveiro, gaining expertise in protocol design, data analysis, and clinical monitoring ๐Ÿ“Š. He earned an MSc in International Health Economics and Policy (2016โ€“2017) from LSE & LSHTM, focusing on pharma economics and cost-effectiveness ๐Ÿ’ถ. His MD in Medicine (2011โ€“2015) from Barts and the London included an elective in Kenya ๐Ÿ‡ฐ๐Ÿ‡ช and a poster presentation at SCMR Nice. He also holds a BSc in Biomedical Sciences (2008โ€“2011) from Queen Mary University, with emphasis on clinical trials and drug design ๐Ÿ’Š.

๐Ÿ’ผ Skills & Personal Interests

Dr. Pierre-Jean Pintard is a multilingual professional, fluent in French ๐Ÿ‡ซ๐Ÿ‡ท and English ๐Ÿ‡ฌ๐Ÿ‡ง, with proficiency in Spanish ๐Ÿ‡ช๐Ÿ‡ธ (C1), and basic knowledge of Portuguese ๐Ÿ‡ต๐Ÿ‡น and German ๐Ÿ‡ฉ๐Ÿ‡ช (A2). His technical skills include MS Word, Excel (with Markov models), STATA, Zinc, Epi-Info, and Spotfire ๐Ÿ’ป. A passionate musician, he studied piano for 9 years at the Conservatoire of Marseille and earned 3rd prize at the Steinway & Sons championship ๐ŸŽน. He is also an avid sailor โ›ต with 13 years of experience at Marseille Yachting Club and Docklands Sailing Centre, holding a sailing instructor license.

Research Focus

Dr. Pierre-Jean Pintardโ€™s research spans across psychiatry, ophthalmology, and cardiology, reflecting a multidisciplinary focus. His early work explored mental health stigma among medical students ๐Ÿง . He has significantly contributed to ophthalmic research, especially in diabetic macular edema, identifying macular volume as a surrogate marker for visual acuity ๐Ÿ‘๏ธ๐Ÿ“Š. In cardiology, he co-authored a study comparing cardiac MRI techniques for assessing left atrial volume, enhancing diagnostic precision โค๏ธ๐Ÿงฒ. His expertise lies in biomarker identification, clinical imaging, and evidence synthesis, highlighting a strong foundation in clinical research and health outcomes across multiple therapeutic areas.

Conclusion

Dr. Pierre-Jean Pintard is highly suitable for the Research for Best Industrial Research Award.
His industrially relevant clinical research, cross-functional leadership, international collaboration, and proven ability to drive patient-centric innovations align with the awardโ€™s objectives.

Publication Top Notes

๐Ÿ“˜ Medical students’ attitudes about mental illness โ€“ PJ Pintard et al. โ€“ ๐Ÿ—“๏ธ 2012 โ€“ ๐Ÿ“Š Cited by: 3 โ€“ ๐Ÿง ๐Ÿฉบ
๐Ÿ“˜ Anatomic biomarkers in diabetic macular edema: Macular volume as a surrogate for visual acuity โ€“ PJ Pintard et al. โ€“ ๐Ÿ—“๏ธ 2025 โ€“ ๐Ÿ“Š Cited by: [Data Pending] โ€“ ๐Ÿ‘๏ธ๐Ÿ“ˆ
๐Ÿ“˜ Cardiac MRI techniques for left atrial volume measurement โ€“ PJ Pintard et al. โ€“ ๐Ÿ—“๏ธ 2015 โ€“ ๐Ÿ“Š Cited by: [Not Specified] โ€“ โค๏ธ๐Ÿงฒ

Sebastian Dierse | Ophthalmology | Best Researcher Award

Dr. Sebastian Dierse | Ophthalmology | Best Researcher Award

Physician, Germany

Dr. Sebastian Dierse (b. 1987, Hamm-Heessen, Germany) is a medical professional specializing in ophthalmology ๐Ÿ‘จโ€โš•๏ธ. He earned his Dr. med. from Heinrich Heine University, Dรผsseldorf, defending his dissertation on neurotrophic keratopathy ๐Ÿง ๐Ÿ‘๏ธ in 2021 under Prof. Dr. med. Gerd Geerling. Since 2021, he has been an Assistant Physician at the University Eye Clinic Mรผnster ๐Ÿฅ. He previously worked in the Sicca outpatient clinic and received the Sicca-Fรถrderpreis (2019) from Bausch & Lomb ๐Ÿ†. Additionally, he co-founded Dierse + Kamppeter GmbH, later sold to brillen.de. His expertise lies in ocular surface diseases and dry eye research ๐Ÿ”ฌ๐Ÿ“–.

Publication Profile

Scopus

Educational Background ๐ŸŽ“๐Ÿ“š

Dr. Sebastian Dierse began his early education at Grundschule Marienschule, Ahlen (1994โ€“1998) ๐Ÿซ. He then attended Bischรถfliches Gymnasium St. Michael, Ahlen, where he successfully completed his Abitur (high school diploma) ๐ŸŽ“. His academic journey from 1998 to 2007 laid a strong foundation for his future in medicine and ophthalmology ๐Ÿ‘๏ธโ€๐Ÿ—จ๏ธ. His commitment to education and excellence has been evident since his early years, setting the stage for his later achievements in medical research and clinical practice ๐Ÿฅ๐Ÿ”ฌ.

Professional Education ๐ŸŽ“๐Ÿ”ฌ

Dr. Sebastian Dierse pursued his professional education with a strong focus on medicine and ophthalmology ๐Ÿ‘๏ธโ€๐Ÿ—จ๏ธ. He began with training in optics at the Berufskolleg fรผr Augenoptik Hans Bรถckler, Mรผnster (2007โ€“2008) ๐Ÿซ. He later completed emergency medical training at the Rettungssanitรคterschule DRK, Mรผnster (2011) ๐Ÿš‘. His medical journey advanced with a premedical course at the Rheinisches Bildungszentrum Kรถln (2013โ€“2014). He then earned his medical degree from Heinrich Heine University, Dรผsseldorf (2014โ€“2021) ๐ŸŽ“. In 2021, he obtained his medical license and defended his dissertation on neurotrophic keratopathy under Prof. Gerd Geerling ๐Ÿฅ๐Ÿ“–.

Professional Experience ๐Ÿ’ผ๐Ÿ‘จโ€โš•๏ธ

Dr. Sebastian Dierse has a diverse professional background, blending entrepreneurship and medical expertise ๐Ÿ‘๏ธโ€๐Ÿ—จ๏ธ. In 2011, he co-founded and managed Dierse + Kamppeter GmbH, Tisco Nord Gbr, expanding its branch network ๐Ÿข. The company was later acquired by brillen.de Aktiengesellschaft in 2011 ๐Ÿฆ. Transitioning into medical practice, he worked as a student assistant at the Sicca Consultation, University Eye Clinic Dรผsseldorf (2018โ€“2019) under Prof. Gerd Geerling ๐Ÿฅ. Since 2021, he has been serving as a residency assistant at the University Eye Clinic Mรผnster under Prof. Eter, specializing in ophthalmology and clinical research ๐Ÿ”ฌ.

Awards & Recognitions ๐Ÿ†๐Ÿ‘จโ€โš•๏ธ

Dr. Sebastian Dierse has been recognized for his outstanding contributions to ophthalmology research ๐Ÿ‘๏ธโ€๐Ÿ—จ๏ธ. In 2019, he was awarded the Sicca-Fรถrderpreis by Bausch + Lomb in Berlin ๐Ÿ…, honoring his work in dry eye disease and related ocular conditions ๐Ÿ”ฌ. This prestigious award reflects his commitment to advancing medical knowledge and improving patient care ๐Ÿฅ. His research has contributed significantly to the understanding of neurotrophic keratopathy, enhancing treatment strategies for affected individuals. Through his dedication and innovation, Dr. Dierse continues to make a meaningful impact in the field of ophthalmology. ๐Ÿ‘จโ€โš•๏ธโœจ

Research Focus ๐Ÿ”ฌ๐Ÿ‘๏ธ

Dr. Sebastian Dierse specializes in ophthalmology, focusing on retinal diseases and ocular imaging ๐Ÿฅ๐Ÿ”. His research explores idiopathic epiretinal membranes (iERMs), emphasizing their pathophysiology, classification, and OCT biomarkers ๐Ÿ“Š. Through advanced optical coherence tomography (OCT), he investigates biomarkers that aid in disease progression and treatment planning. His work contributes to retinal surgery, neuro-ophthalmology, and vision science ๐Ÿ‘จโ€โš•๏ธ๐Ÿง . Collaborating with experts, he advances the early diagnosis and management of retinal disorders, enhancing patient outcomes. His research aligns with retinal imaging, surgical innovations, and ocular pathology, making significant contributions to modern ophthalmic science. ๐Ÿš€๐Ÿ‘๏ธ

Publication

Idiopathic Epiretinal Membranes Pathophysiology, Classifications and OCT-Biomarkers